Thrivent Financial for Lutherans lessened its stake in shares of Livent Co. (NYSE:LTHM) by 0.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 120,432 shares of the company’s stock after selling 667 shares during the period. Thrivent Financial for Lutherans owned 0.08% of Livent worth $2,086,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in LTHM. Marshall Wace LLP acquired a new position in Livent during the first quarter valued at approximately $52,000. First Trust Advisors LP acquired a new position in Livent during the first quarter valued at approximately $1,710,000. Amundi Pioneer Asset Management Inc. acquired a new position in Livent during the first quarter valued at approximately $798,000. Teacher Retirement System of Texas bought a new stake in shares of Livent in the fourth quarter valued at approximately $250,000. Finally, Credit Suisse AG boosted its position in shares of Livent by 82.2% in the fourth quarter. Credit Suisse AG now owns 333,860 shares of the company’s stock valued at $6,290,000 after acquiring an additional 150,626 shares during the period. Institutional investors own 95.93% of the company’s stock.
Shares of NYSE LTHM opened at $19.55 on Thursday. The company has a market capitalization of $2.87 billion, a PE ratio of -162.92, a PEG ratio of 2.98 and a beta of 2.16. The firm’s fifty day moving average is $18.86. Livent Co. has a 52-week low of $6.18 and a 52-week high of $23.99. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.41 and a current ratio of 4.01.
Several research firms have recently weighed in on LTHM. Evercore ISI raised Livent from an “in-line” rating to an “outperform” rating and increased their price objective for the company from $20.00 to $22.00 in a research report on Monday, April 19th. Zacks Investment Research cut Livent from a “hold” rating to a “sell” rating in a research report on Tuesday, May 4th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $17.91.
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.